Literature DB >> 17083933

Cytochalasin D abolishes the schistosomicidal activity of praziquantel.

Livia Pica-Mattoccia1, Cristiana Valle, Annalisa Basso, Anna Rita Troiani, Fabio Vigorosi, Piero Liberti, Alfredo Festucci, Donato Cioli.   

Abstract

To test the hypothesis that calcium channels of schistosomes are the targets for the action of praziquantel, we subjected schistosomes in vitro to pharmacological agents capable of interfering with the functioning of calcium channels. After 1-h exposure to these agents, praziquantel was added and incubation continued overnight. Worms were then washed, resuspended in drug-free medium and observed during the following 7-10 days. About 50% of schistosomes pre-exposed to the calcium channel blockers nicardipine and nifedipine were able to survive a praziquantel concentration (3 microM) that normally killed the majority of adult male worms. Since the organization of the actin cytoskeleton controls the activity of calcium channels in a number of different systems, we also pre-exposed schistosomes to the actin depolymerizing agent cytochalasin D. This treatment rendered the parasites completely refractory to the effects of very high praziquantel levels (up to 36 microM). These results are consistent with the hypothesis that schistosome calcium channels are involved in the mechanism of action of praziquantel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17083933     DOI: 10.1016/j.exppara.2006.09.017

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  14 in total

Review 1.  Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.

Authors:  Nuno Vale; Maria João Gouveia; Gabriel Rinaldi; Paul J Brindley; Fátima Gärtner; José M Correia da Costa
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  In vitro and in vivo activities of arachidonic acid against Schistosoma mansoni and Schistosoma haematobium.

Authors:  Rashika El Ridi; Marwa Aboueldahab; Hatem Tallima; Mohamed Salah; Noha Mahana; Samia Fawzi; Shadia H Mohamed; Omar M Fahmy
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

Review 3.  New insight into praziquantel against various developmental stages of schistosomes.

Authors:  Wei Wu; Wei Wang; Yi-Xin Huang
Journal:  Parasitol Res       Date:  2011-10-08       Impact factor: 2.289

4.  In vitro and in silico evaluation of the schistosomicidal activity of eugenol derivatives using biochemical, molecular, and morphological tools.

Authors:  Isabella Maria Monteiro de Souza; Romulo Dias Novaes; Reggiani Vilela Gonçalves; Felipe Leonardo Bley Fialho; Diogo Teixeira Carvalho; Thiago Belarmino de Souza; Danielle Ferreira Dias; Stefânia Neiva Lavorato; Raquel Lopes Martins Souza; Marcos José Marques; Aline Pereira Castro
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2022-07-01

5.  Towards an understanding of the mechanism of action of praziquantel.

Authors:  Anthony D Aragon; Reza A Imani; Vint R Blackburn; Pauline M Cupit; Sandra D Melman; Tinopiwa Goronga; Thomas Webb; Eric S Loker; Charles Cunningham
Journal:  Mol Biochem Parasitol       Date:  2008-11-28       Impact factor: 1.759

Review 6.  New approaches for understanding mechanisms of drug resistance in schistosomes.

Authors:  Robert M Greenberg
Journal:  Parasitology       Date:  2013-04-03       Impact factor: 3.234

Review 7.  Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges.

Authors:  Rashad Abdul-Ghani; Naguiba Loutfy; Amel el-Sahn; Azza Hassan
Journal:  Parasitol Res       Date:  2009-03-03       Impact factor: 2.289

Review 8.  Novel therapeutic and prevention approaches for schistosomiasis: review.

Authors:  Rashika A F El Ridi; Hatem A-M Tallima
Journal:  J Adv Res       Date:  2012-06-23       Impact factor: 10.479

9.  Transcriptional responses of in vivo praziquantel exposure in schistosomes identifies a functional role for calcium signalling pathway member CamKII.

Authors:  Hong You; Donald P McManus; Wei Hu; Michael J Smout; Paul J Brindley; Geoffrey N Gobert
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

10.  Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade.

Authors:  Anton Simeonov; Ajit Jadhav; Ahmed A Sayed; Yuhong Wang; Michael E Nelson; Craig J Thomas; James Inglese; David L Williams; Christopher P Austin
Journal:  PLoS Negl Trop Dis       Date:  2008-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.